EraNova Metals has filed an independent NI 43-101 technical report confirming robust economics for its 100% owned Adanac Molybdenum Project in British Columbia. The Preliminary Economic Assessment shows a pre-tax NPV of C$1.2 billion and an IRR of 30.8% at a base molybdenum price of US$25/lb, with even stronger results at current spot prices. The project features a 24-year mine life, producing an average of 11.4 million pounds of molybdenum annually, supported by existing infrastructure and permits. EraNova plans to advance feasibility studies and environmental assessments while exploring strategic partnerships to develop the project further.
EraNova Metals' Adanac Molybdenum Project is highlighted alongside Pluang's Basic Materials sector data. For readers following Basic Materials, here is Pluang's market snapshot as of Sep 15, 2026 18:12 WIB: out of 32 priced US stocks, 19 rose and 13 fell. Notable prices include ALB at USD 114.18 (-0.74%), SCCO at USD 186.98 (-0.73%), and NTR at USD 77.52 (+0.68%).
Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...
Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...
Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...
An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...
An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...
